|
|
Volumn 13, Issue SUPPL. 1, 2004, Pages
|
|
Zonisamide clinical trials: European experience
|
|
Author keywords
Efficacy; Epilepsy; Europe; Safety; Zonisamide
|
|
Indexed keywords
CARBAMAZEPINE;
PHENOBARBITAL;
PHENYTOIN;
PLACEBO;
PRIMIDONE;
VALPROIC ACID;
ZONISAMIDE;
ADULT;
ANOREXIA;
APATHY;
ARTICLE;
ATAXIA;
CARCINOMA;
CLINICAL TRIAL;
COMPLEX PARTIAL SEIZURE;
CONCENTRATION LOSS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE RESISTANCE;
DISEASE SEVERITY;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DROWSINESS;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EUROPE;
FATIGUE;
FEMALE;
FOCAL EPILEPSY;
GRAND MAL SEIZURE;
HAIR LOSS;
HEADACHE;
HUMAN;
MAINTENANCE DRUG DOSE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MEMORY DISORDER;
MORBIDITY;
NEPHROLITHIASIS;
NERVOUSNESS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
SOMNOLENCE;
ADULT;
ANTICONVULSANTS;
DEMOGRAPHY;
DOUBLE-BLIND METHOD;
EPILEPSY;
EUROPE;
FEMALE;
HUMANS;
ISOXAZOLES;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 7044228073
PISSN: 10591311
EISSN: None
Source Type: Journal
DOI: 10.1016/j.seizure.2004.04.010 Document Type: Article |
|
Times cited : (33)
|
|
References (5)
|
